Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chondrosarcoma × nilotinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 83 Leukemia, Myeloid, Chronic-Phase 23 Leukemia 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Gastrointestinal Stromal Tumors 14 Blast Crisis 7 Neoplasms 6 Neoplasm Metastasis 6 Philadelphia Chromosome 4 Myeloproliferative Disorders 4 Recurrence 3 Melanoma 3 Leukemia, Myeloid, Acute 3 Leukemia, Myeloid 3 Hematologic Diseases 3 Bronchiolitis Obliterans Syndrome 3 Bone Marrow Diseases 3 Synovitis, Pigmented Villonodular 2 Ovarian Neoplasms 2 Neoplasm, Residual 2 Leukemia, Myeloid, Accelerated Phase 2 Colorectal Neoplasms 2 Substance Withdrawal Syndrome 1 Sarcoma 1 Retroperitoneal liposarcoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Piebaldism 1 Peritoneal Neoplasms 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1

Interventions

Ifosfamide 4 Gemcitabine 4 Filgrastim 4 Doxorubicin 4 Docetaxel 4 Proton Therapy 3 regorafenib 2 enasidenib 2 belinostat 2 Sunitinib 2 Radiotherapy 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 HhAntag691 2 Fluorouracil 2 Etoposide 2 Epirubicin 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 Bevacizumab 2 venetoclax 1 toripalimab 1 temsirolimus 1 tazemetostat 1 tanespimycin 1 spartalizumab 1 resiquimod 1 poly ICLC 1 perifosine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02587169 2015-10-27

GEIS-27

Broto, Javier Martín, M.D.

Phase 1/2 Unknown

Retroperitoneal liposarcoma, Chondrosarcoma, Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡